NOVEL TRANSLOCATOR PROTEIN (TSPO) LIGANDS FOR THE POTENTIAL TREATMENT OF ALZHEIMER'S DISEASE: A NEXT GENERATION ALTERNATIVE TO CONVENTIONAL HORMONE THERAPY